Acetohydroxyacid Synthase (AHAS) Inhibitors as Antitubercular Agents: Insights From Molecular Docking and Dynamics Simulations
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Kunal Gokhale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Acetolactate Synthase, Antitubercular Agents, Molecular Docking Simulation, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Acetohydroxyacid synthase (AHAS) is a vital enzyme in Mycobacterium tuberculosis , the pathogen causing tuberculosis (TB), involved in branched‐chain amino acid synthesis. Targeting AHAS for drug design against TB offers a promising strategy due to its essentiality in bacterial growth. In current investigation, we have designed 160 novel compounds by leveraging key scaffolds identified through structure‐based drug design (SBDD) methodologies. Subsequently, these compounds underwent molecular docking analysis to elucidate their potential interactions with the AHAS protein. The Top 4 compounds (with docking score above −8.2 kcal/mol) resulting from the docking studies were subjected to rigorous molecular dynamics simulations, spanning a runtime of 100 ns, to assess their stability across various parameters including root mean square deviation (RMSD), root mean square fluctuation (RMSF), secondary structure elements (SSEs), radius of gyration (rGyr), solvent accessible surface area (SASA), and MM‐GBSA free energy values. Remarkably, compounds KG 98 and KG 131 exhibited superior stability profiles across all analyzed parameters. From the detailed interactions analysis, it was found that the nitrogen containing heterocyclic rings (1,3,5‐triazine/imidazole) are essential to have the potential binding interactions with the AHAS enzyme. Some of the interactions were persisted for more than 75% of the simulated time, which shows the strength of the interactions. The findings suggest these lead molecules as promising candidates for AHAS inhibition, a potential avenue for TB treatment and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, Maharashtra, India.
ORCID-Profile: RajaSekhar Reddy Alavala
Zitieren
APA
Gokhale, K., Joshi, N., & Alavala, R. R. (2025). Acetohydroxyacid Synthase (AHAS) Inhibitors as Antitubercular Agents: Insights From Molecular Docking and Dynamics Simulations. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402631
Vancouver
Gokhale K, Joshi N, Alavala RR. Acetohydroxyacid Synthase (AHAS) Inhibitors as Antitubercular Agents: Insights From Molecular Docking and Dynamics Simulations. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402631
BibTeX
@article{Gokhale2025,
author = {Gokhale, Kunal and Joshi, Nachiket and Alavala, RajaSekhar Reddy},
title = {Acetohydroxyacid Synthase (AHAS) Inhibitors as Antitubercular Agents: Insights From Molecular Docking and Dynamics Simulations},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402631}
}
EUVIMED